Lauri Lehtimäki

Medicine & Life Sciences

1. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 6%
2. Adrenal Cortex Hormones 20%
3. Air 5%
4. Albuterol 7%
5. anti-IgE antibodies 7%
6. Asthma 100%
7. Biological Products 12%
8. Biological Therapy 10%
9. Bronchoconstriction 9%
10. Bronchodilator Agents 9%
11. Child 7%
12. Chronic Obstructive Pulmonary Disease 7%
13. Complement Factor D 6%
14. Cone-Beam Computed Tomography 8%
15. Cross-Sectional Studies 6%
16. Denmark 5%
17. Dust 8%
18. Dyspnea 11%
19. Eosinophils 10%
20. Exercise 7%
21. Exhalation 5%
22. Finland 29%
23. Guidelines 7%
24. Hospital Emergency Service 5%
25. Humidity 6%
26. Inhalation Spacers 13%
27. Interleukin-5 8%
28. Lung 7%
29. Masks 5%
30. Multimorbidity 5%
31. Multiple Chemical Sensitivity 8%
32. Nasal Polyps 10%
33. Nitric Oxide 21%
34. Nose 7%
35. Occupational Groups 6%
36. Peanut Hypersensitivity 6%
37. Pollen 6%
38. Population 10%
39. Preschool Children 13%
40. Registries 16%
41. Respiratory Insufficiency 7%
42. Respiratory Sounds 9%
43. Respiratory System 6%
44. SARS Virus 10%
45. Scandinavian and Nordic Countries 9%
46. Steroids 8%
47. Sweden 6%
48. Systematic Reviews 5%
49. Valsartan 5%
50. Workplace 13%